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INTRODUCTION
Folding of chromatin in higher order structures is most likely
one of the epigenetic factors conditioning cell type-specific
patterns of gene expression which, finally, results in
approximately 200 cell types arising from the background of
only one genome (Hendrich and Willard, 1995; Strohman,
1997). Polypeptides involved in the cell type-specific structural
organization and modeling of the chromatin fibre belong, as
expected, to the fraction of insoluble nuclear proteins with
strong DNA affinity. In this context, of special interest are
those polypeptides that remain associated with genomic DNA,
especially with highly repetitive DNA sequences (Neuer-
Nitsche et al., 1988; Werner and Neuer-Nitsche, 1989; Pfütz et
al., 1992), even after treatment with harsh denaturants (Neuer
et al., 1983; Juodka et al., 1991). There is evidence for covalent
bonds existing between polypeptides of this fraction and DNA,
because combined and prolonged protease/nuclease treatment
of purified genomic DNA releases molecules comprising
peptide-tyrosine residues and deoxynucleotides linked by
phosphoester bonds (Neuer et al., 1983; Avramova and Tsanev,
1987; Juodka et al., 1991). 
C1D is the first of such polypeptides to have been
characterized at the sequence level. The cDNA encoding this
antigen was first cloned (murine MC1D cDNA, X95591;
human HC1D, X95592; 1995) by expression cloning using a
monoclonal antibody to polypeptides released from rigorously
extracted and nuclease-digested DNA (Nehls et al., 1998).
Later, C1D was also found to be associated with the
transcriptional repressor RevErb and the nuclear corepressors
N-cor and SMRT, which led to the conclusion that it could
function as a component of the complex involved in
transcriptional repression (Zamir et al., 1997). The
involvement of C1D in transcriptional repression would agree
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Apoptosis is induced in various tumor cell lines by vector-
dependent overexpression of the conserved gene C1D that
encodes a DNA-binding and DNA-PK-activating protein.
C1D is physiologically expressed in 50 human tissues tested,
which points to its basic cellular function. The expression of
this gene must be tightly regulated because elevated levels
of C1D protein, e.g. those induced by transient vector-
dependent expression, result in apoptotic cell death. Cells
transfected with C1D-expressing constructs show terminal
deoxynucleotidyl transferase-mediated dUTP nick end-
labeling of DNA ends. Transfections with constructs in
which C1D is expressed in fusion with the (enhanced) green
fluorescent protein from A. victoria (EGFP) allow the
transfected cells to be identified and the morphological
changes induced to be traced. Starting from intense nuclear
spots, green fluorescence reflecting C1D expression
increases dramatically at 12-24 hours post-transfection.
Expression of C1D-EGFP protein is accompanied by
morphological changes typical of apoptotic cell death, e.g.
cytoplasmic vacuolation, membrane blebbing and nuclear
disintegration. Cell shrinkage and detachment from
extracellular matrix are observed in monolayer cultures
while suspension cells become progressively flattened. The
facility to differentiate between transfected and non-
transfected cells reveals that non-transfected cells co-
cultured with transfected cells also show the morphological
changes of apoptosis, which points to a bystander effect. 
C1D-dependent apoptosis is not induced in cells with
non-functional p53. Accordingly, C1D-induced apoptosis is
discussed in relation to its potential to activate DNA-PK,
which has been considered to act as an upstream activator
of p53.
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well with the functional role previously proposed for tightly
DNA-bound polypeptides. However, if so, C1D is apparently
a multifunctional protein because it can serve as a DNA-end
independent activator of the protein kinase DNA-PK (Yavuzer
et al., 1998). Since activation of DNA-PK by DNA ends has
been reported to be the decisive step in radiation-induced
apoptosis (Shieh et al., 1997), it was of interest to study
whether C1D induces apoptosis in nonirradiated cells.
MATERIALS AND METHODS
Expression constructs
The cDNA sections encoding C1D proteins (human C1D, HC1D,
accession no. X95592; murine C1D, MC1D, accession no. X95591)
were PCR-amplified. Restriction sites were added during PCR
amplification. For recombinant expression in E. coli, KpnI (5′ end)
and HindIII (3′ end) sites were added, and the corresponding
amplification products were recloned in the pQE30 vector (Qiagen).
For expression in prokaryotic cells the same products were first
recloned in the pBluescript KS+ vector (Stratagene), then excised by
KpnI/NotI and recloned in the pcDNA3 vector (Invitrogen).
Fusions with the sequence encoding the enhanced green fluorescent
protein (EGFP) were prepared by PCR amplification of the EGFP-
encoding sequence (Clontech) and either KpnI (5′ end)/SalI (3′ end)
sites or SalI (5′ end)/HindIII sites were added during amplification.
The amplification products were recloned in the corresponding sites
of the pBluescript KS+ vector, resulting in the plasmid vectors pBlue-
(KpnI, SalI)-EGFP-(HindIII) (I), and pBlue (KpnI)-EGFP-SalI (II).
Insertion of the KpnI-C1D-SalI amplification product into (I) resulted
in pBlue-C1D-(SalI)-EGFP, and insertion of the SalI-C1D-HindIII
amplification product into (II) resulted in pBlue-EGFP-(SalI)-C1D.
The fused cDNA segments C1D-EGFP and EGFP-C1D were excised
from the pBluescript-constructs with suitable restrictases and recloned
in eukaryotic expression vectors (pcDNA3, pMEP 4; Invitrogen),
pJ3Ω (Morgenstern and Land, 1990) and in the prokaryotic expression
vector pQE30 (Qiagen). For controls, the EGFP sequence was excised
(KpnI, NotI) from the pBluescript construct II and recloned in the
pcDNA3 vector.
Recombinant proteins, mobility shift experiments
C1D proteins and EGFP-tagged C1D proteins were expressed in E.
coli M15. The recombinant proteins were purified by adsorption to
Ni-NTA resin according to the instructions of the producer (Qiagen).
The protein was released from the resin by EDTA in 8 M urea.
Samples were mixed with DNA as described in the legend of Fig. 1
and diluted with TE 0.1 buffer to achieve a final urea concentration
of ≤0.5 M. Samples of such mixtures were subjected to agarose gel
electrophoresis.
RNA master blot
The human RNA masterblot (Clontech, PT3004-1) was
prehybridized (for 3 hours) and hybridized in a rotating tube (at
68°C) with a solution containing 7% SDS, 1 mM EDTA and 0.5 M
sodium phosphate, pH 7.2 (Church and Gilbert, 1984). The HC1D
probe was radiolabelled by [α-32P]dCTP and the Pharmacia Ready-
to-Go DNA labeling kit. Following hybridization the blot was
washed three times with hybridization solution and the stringency
wash was performed with 0.1× citrate-buffered saline (68°C, 2
hours). After drying the blot was exposed to Kodak X-Omat film.
An image of the film was captured by an electronic camera
(Herolab) and relative intensities of the hybridization signals were
estimated by the NIH-image software.
Protein blots
Non-transfected and pcDNA3-MC1D-EGFP-transfected EAT cells
(48 hours post-transfection) were collected by centrifugation and
lysed in 4 volumes of 2× sample buffer containing 5% β-
mercaptoethanol at 95°C, for 3 minutes. Samples containing equal
amounts of proteins and prestained marker proteins were subjected to
SDS-polyacrylamide (12% w/v) gel electrophoresis. Gels were
blotted to nitrocellulose membranes, which were probed with the
polyclonal serum against the recombinant MC1D protein (diluted
1:100 in PBS/1% BSA; Nehls et al., 1998). The second antibody was
125I-labeled anti-rabbit Ig (Amersham).
Identical blots were also probed with an anti-p53 antibody (Santa
Cruz, sc-6243) and with an antibody to p21Cip1(WAF1) (Santa Cruz,
sc-397).
Cells, transfections, microscopy and microphotography
Qia-tip (Qiagen)-purified plasmids were used for transfections.
Suspension cells (Ehrlich ascites tumor (EAT) and HeLa S3 cells)
were transiently transfected with 5-20 µg of plasmid DNA by
electroporation using the Biorad Gene Pulser II (cell density 107/ml,
electrode distance D=4 mm, 366 V/950 µF). Monolayer cells (LCLC
103H, Huh7, M059J) were transiently transfected with FuGene-6
(Roche Molecular Biochemicals) according to the descriptions of the
producer. Briefly, 2.5×105 cells were transfected 16-18 hours post-
seeding on uncoated glass slips in a 5 cm Petri dish containing 4 ml
of the appropriate complete medium by addition of a mixture of 12
µl Fugene-6, 3 µg plasmid DNA and 200 µl serum-free medium. 12-
14 hours post-transfection the slides with transfected cells were
mounted into a closed POC chamber system (LaCon, Ulm,
Germany). 
For control purposes a stably transfected and EGFP-expressing
EAT cell line was prepared by transfection with pcDNA3-EGFP and
G418 selection. In contrast, attempts to achieve a stably transfected
EAT cell line expressing C1D-EGFP by transfection of EAT cells with
pcDNA3-MC1D-EGFP (G418 selection) and with pMEP 4-MC1D-
EGFP (hygromycin selection) were not successful.
Two different Zeiss microscopes for phase contrast and
fluorescence mode (FITC-compatible filters) were in use: (1) a Zeiss
IM35 equipped with a planachromat 63× objective for phase contrast
and fluorescence mode was used for photography of living cells, (2)
a Zeiss Axiovert S100 TV equipped with fluar 40× and 63× ojectives
for phase contrast and fluorescence mode. The latter microscope was
also equipped with a digital electronic camera (Hamamatsu C4742-
95), and controlled by a Power MacIntosh computer (Cell Imaging
software Openlab, Improvision, Warwick, UK). It was used for
capturing fluorescence and bright field images consecutively and for
long-term studies of living cells. 
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL assay)
EAT cells were transiently transfected by electroporation with 20
µg/107 cells with the pcDNA3 vector and with pcDNA3-MC1D
expression construct, respectively. A third culture was supplemented
with Etoposide (5 µM) and another culture remained untreated. After
48 hours the cells were collected, washed with PBS, fixed in 4%
formaldehyde solution and submitted to the in situ cell death detection
assay (Boehringer, Mannheim, Cat. No. 1684795), which was
performed according to the manufacturers’ instructions. Fluorescein
label incorporated was detected by fluorescence microscopy and
images were captured by the electronic camera.
RESULTS
DNA binding characteristics of C1D proteins and
C1D-EGFP fusion proteins
The almost identical (Nehls et al., 1998) human and murine
C1D proteins (16 kDa) expressed in E. coli (Fig. 1A) are
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insoluble in the absence of ionic detergents or chaotropic
agents such as urea or guanidine hydrochloride. The
recombinant EGFP-tagged proteins show similar physico-
chemical characteristics. The C1D and the EGFP-tagged C1D
proteins, however, refold on DNA when mixed with DNA in
8 M urea followed by dialysis or dilution resulting in
urea concentrations ≤0.5 M. The complexes are
electrophoretically stable and result in the DNA mobility
shifts shown in Fig. 1B,E. These mobility shifts are not due
to a change in DNA conformation because digestion of the
complexes with proteinase K releases DNA that migrates like
naked DNA (Fig. 1C). C1D is kept in solution at ≤0.5 M urea
by supercoiled DNA and by linear DNA. However, the
binding affinity to supercoiled DNA is higher than that to
linearized DNA. Only the supercoiled DNA is shifted and
migrates like the linear DNA if equal amounts of supercoiled
and linearized DNA are mixed with a limited amount of C1D
(Fig. 1D). EGFP-tagged C1D shows essentially the same
binding and mobility shift characteristics as the non-tagged
C1D protein (Fig. 1E). The somewhat stronger shift observed
in mixtures with the fusion protein (43 kDa) is consistent with
the higher molecular mass of the DNA-fusion protein
complexes. Fig. 1 displays only the results performed with
the recombinant murine MC1D protein and the recombinant
murine MC1D-EGFP fusion protein, but the human HC1D
protein and its EGFP-tagged derivative show no significant
differences in corresponding assays. 
Ubiquitous expression of the C1D gene
The HC1D cDNA probe hybridizes with poly(A)+ RNAs
from 50 human tissues, suggesting that the gene is expressed
in all human cells, which indicates that the physiological C1D
gene product is an essential component in all cells. The
human RNA masterblot (Clontech PT3004-1) to which
poly(A)+ RNAs from 50 human tissues have been
immobilized in separate dots, along with several controls,
was hybridized with the radiolabelled HC1D cDNA probe.
All dots containing human poly(A)+ RNAs showed positive
hybridization signals when exposed to Kodak X-Omat film
for periods that did not result in hybridization signals with
the negative controls on the same blot (with the exception of
E. coli DNA, which hybridized with the vector sequences
contained in the probe). The relative intensities of the
hybridization signals were recorded by means of the NIH-
image software. Rather low levels of C1D mRNA were
detected in tissues like skeletal muscle, appendix, heart, lung
and colon. Fetal tissues showed generally somewhat higher
C1D expression levels (lung, liver, kidney; 2- to 3-fold).
Expression in several glands (mammary gland, thyroid gland,
salivary gland) was still higher (3- to 4-fold) while the highest
expression was found in hippocampus and medulla oblongata
(4- to 5-fold) (data not shown).
Transient transfection of EAT suspension cells with
the control plasmid pcDNA3-EGFP
The CMV promoter-based expression construct pcDNA3-
EGFP is most suitable for the design of optimal transient
transfection conditions because the vector-dependent
expression can easily be recorded in living cells by means of
the bright EGFP fluorescence. For example, EAT cells show
onset of green fluorescence about 12 hours post-
electroporation in the presence of the pcDNA3-EGFP control
plasmid. Optimal expression is observed at 24-48 hours post-
transfection. The green fluorescence reflecting EGFP is
distributed in the whole cell and no cytotoxic effects are
detectable either in transiently transfected cells or in a stably
transfected cell line (Fig. 2A,B). Transient transfection
efficiencies are in the order of 20-40%. High plasmid
concentrations (20 µg/107 cells) result in a higher percentage
of transfected cells than do low plasmid concentrations (5-10
µg/107 cells). However, there is no strict linear relationship,
and sequential experiments performed under identical
conditions, e.g. the same plasmid concentrations, may result in
different ratios of non-transfected and genetically manipulated
cells. In contrast, parallel assays show rather identical fractions
of transfected cells. Consequently, transfections with the
control plasmid pcDNA3-EGFP were performed throughout in
parallel as an indicator of the efficiency of the transfections
Fig. 1. DNA binding of the recombinant C1D protein. (A) Expression
of MC1D protein in E. coli M15 transformed with the pQE30-MC1D
construct. The figure shows a Coomassie Blue-stained 12%
polyacrylamide gel loaded with the proteins of an E. coli lysate (lane
1) and with MC1D protein (lane 2) isolated by means of Ni-NTA
agarose. (B) MC1D-induced DNA mobility-shift on a 1% (w/v)
ethidium bromide-stained agarose gel. Purified MC1D protein was
folded on a supercoiled plasmid (3 kbp). Lane 1 shows the supercoiled
plasmid without MC1D protein. Lanes 2 and 3 show the mobility of
this plasmid associated with increasing amounts of recombinant
MC1D protein (lane 2, one MC1D molecule per 10 bp; lane 3, two
MC1D molecules per 10 bp). (C) Release of the supercoiled plasmid
after digestion of the MC1D/plasmid complexes with proteinase K.
Lane 1, complexes of the type shown in B, lane 3, were digested with
proteinase K and submitted to a 1% (w/v) ethidium bromide-stained
agarose gel (lane 2). Mainly supercoiled plasmid is released, which
indicates that the mobility shift shown in B is due to a stable DNA-
protein interaction and not caused by a change of DNA conformation,
e.g. linearization of the plasmid. (D) Preferential binding of MC1D
to supercoiled DNA. Samples comprising equal amounts of linearized
and supercoiled plasmid DNA (lane 1) were mixed with increasing
quantities of MC1D protein and analysed on an agarose gel (lane 2)
as described for B. The mobility of the supercoiled plasmid is
significantly reduced at a protein-DNA ratio where the migration of
the linearized conformation remains unchanged. (E) Mobility shift
induced by the MC1D-EGFP fusion protein. The MC1D-EGFP fusion
protein was expressed in E. coli and purified as described for the
MC1D protein (A). It becomes folded, like the MC1D protein, on the
supercoiled plasmid and reduces its mobility, which indicates that the
EGFP portion of the fusion protein does not interfere with the DNA-
binding capacity of the MC1D protein. Lane 1 shows the supercoiled
plasmid and lane 2 shows the mobility-shifted plasmid loaded with
MC1D-EGFP protein.
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with other plasmids (e.g. pcDNA3-C1D) whose expression
cannot be controlled visually. 
Transient transfection of EAT suspension cells with
the pcDNA3-MC1D expression construct
Electroporation of cell cultures generally results in some
mechanically or otherwise damaged cells. Accordingly, it is
almost impossible to differentiate between disrupted cells and
potentially apoptotic cells. Moreover, several methods
commonly used to provide information on apoptosis-related
effects potentially induced by vector-dependent C1D
overexpression are not applicable because the changes in the
20-40% subset of transfected cells become obscured by the
unchanged characteristics of the cells in the larger non-
manipulated fraction. In this situation, the terminal
deoxynucleotidyl transferase-mediated dUTP (fluorescein)
nick end-labeling assay (TUNEL, Boehringer) is the method
of choice to detect apoptosis, because this test allows a
correlation of the size of the cell fraction containing apoptosis-
related DNA strand breaks with the size of the fraction of
genetically manipulated cells. 48 hours post-transfection,
transiently pcDNA3-C1D-transfected EAT cell cultures
contain a subset of cells (10-20%) showing significant
incorporation of the fluorescein label (Fig. 3). The size of this
fraction correlates well with that of EGFP-positive cells in
parallel assays transfected with the control plasmid pcDNA3-
EGFP, suggesting that pcDNA3-MC1D-transfected cells are
the positives in the TUNEL assay. As mentioned above the
electroporation procedure results in some damaged and
obviously non-viable cells. Such cells can also be detected in
the cultures transfected as a control with the pcDNA3 vector.
In vector controls, however, these physically injured cells show
no significant fluorescence label, which points to the
significance of the TUNEL assay. Actually, inspection of
several hundred cells from vector-transfected assays alone
revealed less than 1% of significantly fluorescein-labelled
cells. Significant fluorescein label is also detected in cells of
Etoposide-treated cultures (5 µM), but the fraction of
Etoposide-induced positive cells is significantly smaller (≤5%)
than that induced by pcDNA3-C1D transfection. Accordingly,
these results can be considered as the first evidence for
induction of apoptosis by vector-dependent overexpression of
C1D.
Transient transfection of EAT suspension cells with
the pcDNA3-MC1D-EGFP expression construct
Transfections with EGFP-tagged MC1D expression constructs
allow the transfected cells to be identified and the
morphological changes induced by vector-dependent
overexpression to be traced in single cells. In a first series of
experiments suspension cells (EAT and Hela S3) were
transfected by electroporation in the presence of pcDNA3-
MC1D-EGFP. The results obtained with these two cell lines
were rather similar and only EAT cell data are shown.
Transfected EAT cells elicite nuclear onset of green
fluorescence about 9-12 hours post-transfection. Later stages
are characterized by an increasing fluorescent spot, which
develops in the cell nucleus. This process is accompanied by
morphological changes typical for apoptotic cell death, e.g.
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Fig. 2. Morphology of EAT cells stably transfected with pcDNA3-
EGFP, transiently transfected with pcDNA3-MC1D-EGFP and
cultured in the presence of 5 µM Etoposide, respectively. (A,B) EAT
cells stably transfected with the control plasmid pcDNA3-EGFP in
bright field (A) and in fluorescence mode (B). The morphology and
the viability of the cells indicate that the enhanced green fluorescent
protein (EGFP) itself has no cytotoxic effects. (C) The morphology
of an EAT cell transiently transfected with the pcDNA3-MC1D-
EGFP expression construct (48 hours post-transfection, simultaneous
bright field and fluorescence mode). For comparison (D) shows an
EAT cell with the typical morphology of apoptotic cells in cultures
supplemented with 5 µM Etoposide (only bright field). Zeiss IM35,
phase 63×.
Fig. 3. Terminal deoxynucleotidyl transferase-mediated dUTP
(fluorescein) nick end-labeling (TUNEL assay) following
transfection of EAT cells with pcDNA3-MC1D. EAT cells were
transiently transfected with the MC1D expression construct
pcDNA3-MC1D. At 48 hours post-transfection the cells were
collected, fixed, and submitted to a procedure which adds
fluorescein-labeled dUTP at 3′-OH ends of DNA breaks. The upper
row of micrographs shows cells in bright field. The lower row shows
the same fields in fluorescence mode (FITC filter set). Images were
captured by means of an electronic camera. Improvision Openlab
system, Zeiss S100 TV, phase 40×. Bars, 10 µm.
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cytoplasmic vacuolation, membrane blebbing and, finally,
nuclear disintegration (Fig. 4). The conclusion of apoptotic cell
death of transfected cells is supported by comparison of the
rather identical morphologies of pcDNA3-MC1D-EGFP-
transfected cells (Fig. 2C) with those triggered into apoptosis
by 5 µM Etoposide, respectively (Fig. 2D). In contrast to
monolayer cells, EAT cells show no shrinkage and become
progressively flattened during apoptosis. Cells of a transfected
culture go asynchronously through this process, e.g. cells with
complete nuclear disintegration can be observed as soon as 24
hours post-transfection while cells showing only intense
nuclear fluorescent spots are still found 48 hours post-
transfection. 
Stably transfected cell lines expressing the non-toxic EGFP
can be easily prepared by G418 selection of pcDNA3-EGFP
transfected EAT cells (Fig. 2A,B). In contrast, no fluorescent
EAT cells survive during G418 selection of pcDNA3-C1D-
EGFP-transfected cells, which is a further indication for the
cytotoxic effect of over-physiological levels of C1D.
The cytotoxic effects of C1D overexpression are not species-
specific. Expression constructs containing the human C1D
sequence are as effective in murine cells as in human cells and
vice versa (not shown). 
Transient transfection with other EGFP-tagged
MC1D expression constructs
The relative positions of the C1D and EGFP sequences in the
fusion proteins do not change the effectiveness of the
constructs because transient transfection with either pcDNA3-
MC1D-EGFP or pcDNA3-EGFP-MC1D induces the
morphological changes described in Figs 2 and 4. These
changes are also observed following transfection with an
expression construct driven by the weaker SV40 early
promoter (pJ3Ω-MC1D-EGFP), which indicates that a minor
increase of C1D expression is sufficient to induce the cytotoxic
effects. This conclusion is also supported by unsuccessful
attempts to generate stable transfectants using the
metalotionein promoter-based pMEP 4-MC1D-EGFP
construct. Before hygromycin selection in the absence of metal
ions a fraction of cells shows barely detectable fluorescence,
which points to low-level expression of MC1D-EGFP under
these conditions. Apparently, the residual transcriptional
Fig. 4. Stages of cell death
following transient
transfection of EAT cells with
the expression construct
pcDNA3-MC1D-EGFP.
Living EAT cells transiently
transfected and inspected 24-
48 hours post-transfection
show morphological changes
including (from left to right)




blebbing and finally nuclear
disintegration. The
micrographs in the upper row
show the transfected EAT
cells in bright field; those in
the lower row show the same
cells in fluorescence mode (FITC filter set). It should be noted that cells transfected with other C1D expression constructs (e.g. pcDNA3-EGFP-
MC1D, pJ3Ω-MC1D-EGFP, pcDNA3-HC1D-EGFP) show essentially the same morphological changes. Zeiss IM35, phase 63×.
Fig. 5. Estimation of the level of vector-dependent MC1D-EGFP
expression, p53 expression and p21Cip1(WAF1) expression in EAT
cells. Autoradiography of a 12% (w/v) SDS polyacrylamide gel
loaded with total cellular protein from non-transfected EAT cells (lane
1), and from EAT cells transiently transfected with the expression
construct pcDNA3-MC1D-EGFP (lanes 2 and 3). Following
electroblotting the nitrocellulose membrane was probed with an
MC1D-specific antibody and 125I-labeled anti rabbit Ig (Amersham).
Transfected cells (lane 2, 5 µg of plasmid/107 cells; lane 3, 20 µg of
plasmid/107 cells) were harvested 48 hours post-transfection. It
should be noted that MC1D is present in EAT cells in a monomeric
(M) and in dimeric forms (D) (Nehls et al., 1998). Molecular masses
refer to a prestained protein marker present on the gel (not shown).
The same protein lysates were used for identical blots, which were
probed with antibodies specific for p53 and p21Cip1(WAF1)
respectively. Only the relevant sections of the latter blots are shown.
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activity of the non-induced metalotionein promoter is sufficient
to produce low but lethal amounts of the MC1D-EGFP protein.
Accordingly, all cells die during hygromycin selection. The
transfected cells are killed because they express MC1D-EGFP
and the non-transfected cells because they are not hygromycin-
resistant.
Quantitation of MC1D-EGFP expression in EAT
suspension cells
The intense fluorescence of the EGFP protein is a most
sensitive tool for identifying transfected cells; however, it may
be unreliable with respect to the actual quantity of EGFP-
tagged C1D, which is lethal for transfected cells. More
reliable estimates would be expected from protein blots
probed with C1D-specific antibody. However, there is a
problem with this technique in that the C1D-EGFP protein
present in transfected cells is diluted by protein from the
fraction of non-transfected cells. Fig. 5 shows a protein blot
loaded with equal amounts of total cellular proteins from non-
transfected EAT cells and from EAT cells transfected with
increasing amounts of the pcDNA3-MC1D-EGFP plasmid. It
should be noted that the endogenous C1D protein is present
in EAT cells in a monomeric (16 kDa) and in non-disulfide-
bonded dimeric (32 kDa) forms (Nehls et al., 1998). The
MC1D-specific serum detects the endogenous 16 kDa and 32
kDa proteins on the three lanes while it detects a protein of
43 kDa, which is the molecular mass of the MC1D-EGFP
fusion protein, only on the lanes loaded with protein from
transfected EAT cells (Fig. 5). The fusion protein signal on
the lane loaded with protein from cells transfected with 20
µg/107 cells is almost as intense as the signal(s) of the
endogenous C1D. Since the transfection efficiency was about
40% it can be included that a two- to threefold increase of the
C1D level induces the cytotoxic effects.
Membrane irritation and morphological changes of
non-transfected cells cocultured with pcDNA3-
MC1D-EGFP- and pcDNA3-HC1D-EGFP-transfected
cells
The EGFP-dependent differentiation between transfected and
non-transfected cells allows us to investigate the fate of the
population of apparently non-transfected cells cocultured with
transfected cells. Microscopical inspection of pcDNA3-
MC1D-EGFP-transfected EAT cultures revealed membrane
changes of non-fluorescent cells, suggesting the release of
cytotoxic factors from transfected cells dying by apoptosis
(Fig. 6). These effects are preferentially seen in experiments
with high transfection efficiencies (≥20%). Although the cells
are kept in full medium during microscopical observation these
morphological changes could be due to the non-optimal culture
conditions. 
This bystander effect is also observed, however, after
transfection of human lung cancer-derived LCLC 103H
monolayer cells cultured and microscopically inspected under
more optimal culture conditions. LCLC 103H cells show, like
EAT cells, no significant changes of the cell morphology and
cell growth when transfected with the pcDNA3-EGFP control
construct. They grow up during 48 hours forming a perfect
monolayer (Fig. 7A,A′). In contrast, 48 hours post-
transfection with the HC1D-EGFP-expressing construct, the
transfected cells and almost all of the apparently non-
transfected cells show shrinkage and detachment from the
support (Fig. 7B,B′). The transfected LCLC 103H monolayer
cells can be long-term cultured and microscopically inspected
under almost optimal culture conditions using a temperature-
controlled incubation chamber (Pentz and Hörler, 1992). This
device allows us to study dynamic processes post-transfection
with the pcDNA3-HC1D-EGFP expression construct (Fig. 8).
Onset of green fluorescence is observed 8-12 hours post-
transfection. This initial green fluorescence, indicating EGFP-
tagged HC1D expression, is located, like in EAT suspension
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Fig. 6. Morphological changes of non-transfected EAT cells
cocultured with transfected EAT cells. A group of EAT cells from a
transiently pcDNA3-MC1D-EGFP-transfected culture was observed
for 1 hour in full medium under the microscope. Observation started
at 36 hours post-transfection. The uppermost image was captured
only in fluorescence mode while the other images were captured
under simultaneous bright field and fluorescence mode. Only one cell
of this group is transfected because it shows bright fluorescence. At
the time the observation began (0′) the bystander cells showed a
rounded morphology, which is typical for EAT cells. Arrows point to
membrane changes of non-transfected cells arising during the
observation period (10-60 minutes). Zeiss IM35, phase 6×.
2229C1D-induced apoptosis
cells, in dense nuclear spots (Fig. 8). Later, as shown at 24
hours, the transfected cells show bright fluorescence,
predominantly in cell nuclei. In addition Fig. 8 shows a
selected field comprising only one transfected cell. Continued
observation of this highly fluorescent cell for another 4 hours
shows retraction of the plasma membrane, cell shrinkage and
detachment from the support. Concomitantly the apparently
non-transfected bystander cells show similar morphological
changes which, in this case, cannot be attributed to non-
optimal culture conditions. Finally, at 48 hours post-
transfection this bystander effect leads to about 50% of
detached and spherical-shaped cells, while only about 10% of
the cells appear to be transfected and exhibit significant green
fluorescence (not shown). The cytotoxic factors inducing this
bystander effect are unknown. However, they appear to
possess rather short half-life times because the cytotoxic
effects could not be induced in non-transfected cultures by
conditioned medium taken from transfected EAT or LCLC
103H cultures.
Exploration of the mechanism involved
The putative mechanism for C1D-induced apoptosis predicts
DNA-end independent activation of DNA-PK with the
consequence of p53 phosphorylation and activation of its
downstream effectors. This assumption is based on the fact
that C1D interacts in vivo with DNA-PK and that DNA-PK is
activated by C1D in a DNA end-independent manner (Yavuzer
et al., 1998). Accordingly, DNA-PK deficient cells, e.g.
M059J cells (Lees-Miller et al., 1995), should escape C1D-
induced apoptosis. However, this approach meets with
technical problems. Regular M059J cell cultures contain a
significant fraction of dying and detached cells. This fraction
increases post-transfection with any plasmid DNA, e.g. with
the control plasmid pcDNA3-EGFP. Accordingly it is difficult
to differentiate between C1D-dependent effects and the effects
induced by the transfection procedure. Viable and C1D-EGFP
transfected cells can be found at 12-24 hours post-
transfection; however, this fraction is low and neither proves
nor disproves the insensitivity of M059J cells to C1D-induced
apoptosis. 
In contrast, the downstream steps of the proposed
mechanism are supported by additional experimental
evidence. Wild-type p53 appears to be required for C1D-
induced apoptosis in cells where p53 cannot be replaced by
functionally related proteins. Huh7 cells are known to possess
mutated and non-functional p53, and p53 function is not
replaced in these cells by functionally similar proteins (Muller
et al., 1997). Following transfection with the C1D-EGFP
expression construct these cells grow up and form perfect
monolayers (Fig. 9). At higher magnification the C1D-EGFP-
expressing cells appear to be well spread and without
morphological changes that are typical for apoptosis, e.g. they
do not show membrane retraction, detachment and plasma
vacuolization. 
The p53 level itself remains unchanged in C1D-EGFP-
transfected cells (Fig. 5B), which is to be expected because
p53 activation is due to phosphorylation rather than
increased expression (Shieh et al., 1997). In contrast,
expression of the p53 downstream effector p21Cip1(WAF1)
is significantly increased in C1D-EGFP transfected cells
(Fig. 5C). It should be noted that the induction of
p21Cip1(WAF1) expression is somewhat underestimated by
Fig. 7. LCLC 103H cells transfected with the
control construct pcDNA3-EGFP and the
HC1D-EGFP-expressing construct pcDNA3-
HC1D-EGFP. The cells of an LCLC 103H
culture transiently transfected with the control
plasmid pcDNA3-EGFP show, 48 hours post-
transfection, perfect cell morphology. The
cells grow up during this period normally and
form a dense monolayer (A, bright field; A′,
fluorescence mode, FITC filter set). Two cells
of this group are transfected and express
significant amounts of EGFP, which has
apparently no toxic effect. In contrast, LCLC
103H cells transfected with the expression
construct pcDNA3-HC1D-EGFP show, 48
hours post-transfection, disturbed morphology,
especially shrinkage and detachment (B,
bright field; B′, fluorescence mode, FITC filter
set). It should be noted that all cells in this
field show disturbed morphology whether they
are transfected or not. Improvision Openlab
system, Zeiss Axiovert S100 TV, phase 40×.
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the western blot shown in Fig. 5 because only about 40% of
the cells are transfected. 
DISCUSSION
Apoptosis is induced by many and rather different
environmental stimuli, such as treatments with various drugs
and death factors like Fas ligand or TNF α, cell injury,
irradiation, viral infection and growth factor deprivation. Any
of these exogenous factors or treatments is able to activate a
genetic program that culminates in apoptotic cell death. A
large number of gene products that are required for, favour or
inhibit apoptosis induced by exogenous factors have been
identified in lower and higher eukaryotes. Moreover,
intracellular death signals play a major role during
development; e.g. it has been reported that in organisms such
as the nematode C. elegans large numbers of cells are
eliminated by programmed cell death during development
(Sulston and Horvitz, 1977; Ellis et al., 1991), which indicates
that cells can activate their own suicide programs. However,
cellular genes which are able to initiate the programmed cell
death, e.g. by transient overexpression, are rather rare. The IL-
1β-converting enzyme (ICE), which is a mammalian homolog
of the C. elegans cell death gene ced-3, has been reported to
induce apoptosis in fibroblasts (Miura et al., 1993). Other
examples include the Drosophila proteins HID and GRIM,
whose transient overexpression induce apoptosis in SF-21
cells (Vucic et al., 1998). Overexpression of a serine/threonine
kinase, designated ZIP kinase, has been reported to induce the
morphological changes of apoptosis in NIH 3T3 cells (Kawai
et al., 1998). 
In this paper we present evidence for the induction of
programmed cell death of various tumor cells by transient
overexpression of the conserved 16 kDa DNA-binding protein
C1D. Several criteria suggest that the C1D-induced cell death
occurs by apoptosis rather than by necrosis. The fraction of
terminal transferase-labeled cells corresponds with the
fraction of C1D-transfected cells and the morphological
changes induced by overexpression of EGFP-tagged C1D are
typical for apoptotic cell death. Surprisingly, the endogenous
C1D gene is ubiquitously expressed. Apparently,
physiological levels of this protein are harmless and most
probably essential for the cell. However, in the tumor cells
tested, additional quantities of the gene product are not
tolerated, with the consequence of cell death. These additional
quantities inducing the cytotoxic effects are rather low and it
should be noted that the bright fluorescence of the EGFP-
tagged C1D protein overestimates the true amount of the
vector-expressed C1D protein. Blots loaded with protein from
transfected EAT cell cultures show that the C1D level is
increased at most two- to threefold in transfected cells. Since
the C1D expression levels of different tissues cover a
broader range (one- to fivefold) it must be concluded that the
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Fig. 8. Long-term microscopical observation of LCLC
103H cells transfected with pcDNA3-HC1D-EGFP.
Transiently transfected LCLC 103H cells cultured in a
temperature-controlled incubation chamber (Pentz and
Hörler, 1992) show nuclear onset of green fluorescence
8-12 hours post-transfection (8 hours). 24 hours post-
transfection the transfected cells show bright and
predominantly nuclear fluorescence (24 hours). During a
further 4 hour observation period the transfected cell
shows shrinkage (24+4 h; retraction of the plasma
membrane, arrows). Concomitantly the apparently non-
transfected cells of this group show similar
morphological changes. They become progressively
spherical-shaped and detached from the support. Openlab
Improvision system, Zeiss S100 TV, phase 40×.
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expression level of the endogenous gene is cell type-
specifically regulated and that different cell types require
and/or tolerate different levels of C1D protein.
The induction of apoptosis by overexpression of C1D
paralleled by increasing levels of p21Cip1(WAF1), and
missing apoptosis in cells with non-functional p53, correlate
well with previously published data on the specific interaction
of the C1D protein with DNA-PK. The latter enzyme is
known to be activated by DNA strand breaks, e.g. by those
generated by γ-irradiation (Anderson and Lees-Miller, 1992;
Jackson, 1997; Smith et al., 1998). The DNA end-activated
enzyme phosphorylates p53 at SER 15 and SER 37, resulting
in p53 activation and in p53-dependent radiation-induced
apoptosis (Shieh et al., 1997). This pathway also appears to
be inducible by overexpressed C1D in the absence of DNA
ends. It has been shown that C1D directs the activation of
DNA-PK in a manner that does not require DNA termini.
Moreover, DNA-PK activated by C1D is able to
phosphorylate p53 (Yavuzer et al., 1998). Accordingly, C1D-
induced apoptosis can be consistently explained by the
assumption that overexpression of C1D mimics or substitutes
DNA strand breaks, resulting in an initial DNA end-
independent activation of DNA-PK, which results in p53
activation and finally in apoptosis. 
While the induction of apoptosis in C1D-overexpressing
cells can be consistently explained, there is at present no such
explanation for the morphological changes of the bystander
cells, which are apparently non-transfected with the constructs
expressing EGFP-labeled C1D. Unknown factors released by
the transfected and dying cells must be postulated. However,
it cannot be ruled out unequivocally that the non-fluorescent
cells are indeed transfected and express EGFP-tagged protein
in amounts that cannot be detected by fluorescence
microscopy but which are sufficient to induce the
morphological changes. 
It has been suggested that survival of tumor cells in all or
in part is due to their inability to activate a suicide program
(Donehower et al., 1992). In this paper it is shown that
vector-dependent overexpression of C1D can override this
failure of tumor cells in vitro, provided that p53 function is
retained. The in vivo application of this procedure would
meet the basic problems of gene therapy, consisting of
insufficient transfection rates of the target cells by
appropriate vector systems. However, all cells of an
organism, including tumor cells, do contain the C1D gene.
Thus it should be possible to substitute the vector-dependent
overexpression of C1D by stimulation of the endogenous
C1D promoter. Accordingly, the identification of the
promoter which regulates the physiological C1D expression
and the search for factors or procedures which could
systemically activate the C1D promoter seems a promising
task.
One of us (B. J.) is grateful for a guest scientist fellowship provided
by the German Cancer Research Center, Heidelberg. The authors
thank P. Jeggo (University of Falmer, UK) for supplying M059J cells,
J. Turner (Cross Cancer Institute, Edmonton, Canada) for permission
to use these cells, and C.-H. Schroeder (German Cancer Research
Center) for giving us Huh7 cells.
REFERENCES
Anderson, C. W. and Lees-Miller, S. P. (1992). The nuclear serine/threonine
protein kinase DNA-PK. Crit. Rev. Euk. Gene Exp. 2, 283-314.
Avramova, Z. and Tsanev, R. (1987). Stable DNA protein complexes in
eukaryotic chromatin. J. Mol. Biol. 196, 437-440. 
Church, G. M. and Gilbert, W. (1984). Genomic sequencing. Proc. Natl.
Acad. Sci. USA 81, 1991-1995.
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J.,
Montgomery, C. A., Butel, J. S. and Bradley, A. (1992). Mice deficient
for p53 are developmentally normal but susceptible to spontaneous tumors.
Nature 356, 215-221.
Ellis, R. E., Yuan, J. and Horvitz, H. R. (1991). Mechanisms and functions
of cell death. Ann. Rev. Cell Biol. 4, 663-689.
Hendrich, B. D. and Willard, H. F. (1995). Epigenetic regulation of gene
expression: the effect of altered chromatin structure from yeast to mammals.
Hum. Mol. Genet. 4, 1765-1777.
Jackson, S. P. (1997). DNA-dependent protein kinase. Int. J. Biochem. Cell.
Biol. 29, 935-938.
Juodka, B., Pfütz, M. and Werner, D. (1991). Chemical and enzymatic
analysis of covalent bonds between peptides and chromosomal DNA.
Nucleic Acids Res. 19, 6391-6398.
Fig. 9. pcDNA3-HC1D-EGFP transfection of cells (Huh7) with non-
functional p53. Transiently transfected Huh7 cells are growing
normally and they form a monolayer at about 48 hours post-
transfection (upper image, overview). Inspection of individual cells
of such cultures at higher magnification shows that the morphology
of the transfected cells is unchanged when compared with non-
transfected cells. The transfected cells remain well spread and
attached to the support (lower image). The images represent merged
layers captured sequentially in phase contrast and fluorescence mode.
Openlab Improvision software, Zeiss S100. Bars, 50 µm.
2232
Kawai, T., Matsumoto, M., Takeda, K., Sanjo, H. and Akira, S. (1998).
ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol.
Cell. Biol. 18, 1642-1651.
Lees-Miller, S. P., Godbout, R., Chan, D. W., Weinfeld, M., Day, R. S.,
Barron, G.M. and Allalunis-Turner, J. (1995). The absence of p350
subunit of DNA-activated protein kinase from a radiosensitive human cell
line. Science 267, 1183-1185.
Miura, M., Zhu, H., Rotello, R., Hartwig, E. A. and Yuan, J. (1993).
Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a
mammmalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-
660.
Morgenstern, J. P. and Land, H. (1990). A series of mammalian expression
vectors and characterisation of a reporter gene in stably and transiently
transfected cells. Nucleic Acids Res. 18, 1068.
Muller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H.,
Hofmann, W. J., Stremmel, W., Krammer, P. H. and Galle, P. R. (1997)
Drug-induced apoptosis in hepatoma cells is mediated by the CD5 (Apo-
1/Fas) receptor/ligand system and involves wild-type p53. J. Clin. Invest.
99, 403-413.
Nehls, P., Keck, T., Greferath, R., Spiess, E., Glaser, T., Rothbarth, K.,
Stammer, H. and Werner, D. (1998). cDNA cloning, recombinant
expression and characterization of polypeptides with exceptional DNA
affinity. Nucleic Acids Res. 26, 1160-1166.
Neuer, B., Plagens, U. and Werner, D. (1983). Phosphodiester bonds
between polypeptides and chromosomal DNA. J. Mol. Biol. 164, 213-
235.
Neuer-Nitsche, B., Lu, X. and Werner, D. (1988). Functional role of a highly
repetitive DNA sequence in anchorage of the mouse genome. Nucleic Acids
Res. 16, 8351-8360.
Pentz, S. and Hörler, H. (1992). A variable cell culture chamber for open and
closed cultivation, perfusion and high microscopic resolution of living cells.
J. Microsc. 167, 97-103.
Pfütz, M., Gileadi, O. and Werner, D. (1992). Identification of human
satellite DNA sequences associated with chemically resistant nonhistone
polypeptide adducts. Chromosoma (Berlin) 101, 609-617.
Shieh, S.-Y., Ikeda, M., Taya, Y. and Prives, C. (1997). DNA damage-
induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91,
325-334.
Smith, G. C. M, Dicheva, N., Lakin, N. D. and Jackson, S. P. (1998). The
DNA-dependent protein kinase and related proteins. Biochem. Soc. Symp.
64, 87-100.
Strohman, R. C. (1997). The coming Kuhnian revolution in biology. Nature
Biotechnol. 15, 194-200.
Sulston, J. and Horvitz, H. R. (1977). Postembryonic cell lineages of the
nematode C. elegans. Dev. Biol. 82, 110-156.
Werner, D. and Neuer-Nitsche, B. (1989). Site-specific location of covalent
DNA-polypeptide in the chicken genome. Nucleic Acids Res. 17, 6005-
6015.
Yavuzer, U., Smith, G. C. M., Bliss, T., Werner, D. and Jackson, P. (1998).
DNA end-independent activation of DNA-PK is mediated via association
with the DNA-binding protein C1D. Genes Dev. 12, 2188-2199.
Vucic, D., Kaiser, W. J. and Miller, L. K. (1998). Inhibitor of apoptosis
proteins physically interact with and block apoptosis induced by Drosophila
proteins HID and GRIM. Mol. Cell. Biol. 18, 3300-3309.
Zamir, I., Dawson, J., Lavinsky, R. M., Glass, C. K., Rosenfeld, M. G. and
Lazar, M. A. (1997). Cloning and characterization of a corepressor and
potential component of the nuclear hormone receptor repression complex.
Proc. Natl. Acad. Sci. USA 94, 14400-14405.
K. Rothbarth and others
